Baricitinib as potential treatment for 2019-nCoV acute respiratory disease

Lancet. 2020 Feb 15;395(10223):e30-e31. doi: 10.1016/S0140-6736(20)30304-4. Epub 2020 Feb 4.
No abstract available

Publication types

  • Letter

MeSH terms

  • Azetidines / therapeutic use*
  • Betacoronavirus / drug effects*
  • COVID-19
  • Coronavirus Infections / drug therapy*
  • Humans
  • Pandemics
  • Pneumonia, Viral / drug therapy*
  • SARS-CoV-2
  • Sulfonamides / therapeutic use*

Substances

  • Azetidines
  • Sulfonamides
  • baricitinib

Supplementary concepts

  • COVID-19 drug treatment